Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Financing › Details

Biocartis–SEVERAL: investment, 201901 private placement €55.5m of 5m new shares at €11.1/share

	Period	2019-01-23
	Predecessor	Biocartis–SEVERAL: investment, 201711 private placement €80m of 6.4m new shares at €12.5/share
	Money taker	Biocartis Group N.V. (Euronext Brussels: BCART)
	Group	Biocartis (Group)
	Money source	SEVERAL
	Product	Idylla™ molecular diagnostics system
	Product 2	investment banking
	Source	Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Successfully Raises EUR 55.50 Milion in an Equity Placement [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen.

Record changed: 2020-01-06

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Biocartis (Group)

[1] Biocartis Group N.V.. (5/9/23). "Press Release: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test". Mechelen....
[2] Biocartis Group N.V.. (4/11/23). "Press Release: Biocartis Appoints Roger Moody as New CEO". Mechelen....
[3] Biocartis Group N.V.. (4/4/23). "Press Release: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla Platform". Mechelen....
[4] NeoGenomics, Inc.. (5/9/22). "Press Release: NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary". Ft. Myers, FL....
[5] Biocartis Group N.V.. (10/6/20). "Press Release: Biocartis Announces Market Release of SeptiCyte RAPID Test on Idylla". Mechelen....
[6] Biocartis Group N.V.. (9/30/20). "Press Release: Biocartis Receives EUR 1.2 Million Grant for Development of Highly Innovative Idylla GeneFusion Assay". Mechelen....
[7] Biocartis Group N.V.. (9/1/20). "Press Release: Biocartis Expands Collaboration with LifeArc". Mechelen & London....
[8] Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces 2019 Results and 2020 Outlook". Mechelen....
[9] Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla MSI test in China". Mechelen....
[10] Biocartis Group N.V.. (1/27/20). "Press Release: Biocartis Announces Resignation of CFO". Mechelen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]